Radiation-induced gliomas

References

• Stupp R, Mason WP, van den Bent MJ et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med.352(10), 987–996 (2005).
   PubMed Web of Science ®Google Scholar
• Stupp R, Hegi ME, Mason WP et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised Phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol.10(5), 459–466 (2009).
   PubMed Web of Science ®Google Scholar
• Cahan WG, Woodard HQ, Higinbotham NL, Stewart FW, Coley BL. Sarcoma arising in irradiated bone: report of 11 cases: 1948. Cancer82(1), 6–34 (1998).
   PubMed Web of Science ®Google Scholar
• Neglia JP, Robison LL, Stovall M et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the childhood cancer survivor study. J. Natl Cancer Inst.98(21), 1528–1537 (2006).
   PubMed Web of Science ®Google Scholar
• Sadetzki S, Chetrit A, Freedman L, Stovall M, Modan B, Novikov I. Long-term follow-up for brain tumor development after childhood exposure to ionizing radiation for tinea capitis. Rad. Res.163, 424–432 (2005).
   PubMed Web of Science ®Google Scholar
• Karlsson P, Holmberg E, Lundell M, Mattsson A, Holm LE, Wallgren A. Intracranial tumors after exposure to ionizing radiation during infancy: a pooled analysis of two Swedish cohorts of 28,008 infants with skin hemangioma. Rad. Res.150, 357–364 (1998).
   PubMed Web of Science ®Google Scholar
• Diallo I, Haddy N, Adjadj E et al. Frequency distribution of second solid cancer locations in relation to the irradiated volume among 115 patients treated for childhood cancer. Int. J. Rad. Biol. Phys.74(3), 876–883 (2009).
   PubMed Web of Science ®Google Scholar
• Klein EE, Maserang B, Wood R, Mansur D. Peripheral doses from pediatric IMRT. Med. Phys.33(7), 2525–2531 (2006).
   PubMed Web of Science ®Google Scholar
• Mansur DB, Klein EE, Maserang BP. Measured peripheral dose in pediatric radiation therapy: a comparison of intensity-modulated and conformal techniques. Radiother. Oncol.82, 179–184 (2007).
   PubMed Web of Science ®Google Scholar
• Linet MS, Kim KP, Rajaraman P. Children’s exposure to diagnostic medical radiation and cancer risk: epidemiologic and dosimetric considerations. Pediatr. Radiol.39(Suppl. 1), S4–S26 (2009).
   PubMed Web of Science ®Google Scholar
• Paulino AC, Mai WY, Chintagumpala M, Taher A. Radiation-induced malignant gliomas: is there a role for reirradiation. Int. J. Rad. Biol. Phys.71(5), 1381–1387 (2008).
   PubMed Web of Science ®Google Scholar
• Cardis E, Vrijheid M, Blettner M et al. The 15-country collaborative study of cancer risk among radiation workers in the nuclear industry: estimates of radiation-related cancer risks. Rad. Res.167, 396–416 (2007).
   PubMed Web of Science ®Google Scholar
• Yonehara S, Brenner AV, Kishikawa M et al. Clinical and epidemiologic characteristics of first primary tumors of the central nervous system and related organs among atomic bomb survivors in Hiroshima and Nagasaki, 1958–1995. Cancer101(7), 1644–1654 (2004).
   PubMed Web of Science ®Google Scholar
• Rahu M, Rahu K, Anuvinen A et al. Cancer risk among Chernobyl cleanup workers from Estonia and Latvia, 1986–1998. Int. J. Cancer119, 162–168 (2006).
   PubMed Web of Science ®Google Scholar
• Sodickson A, Baeyens PF, Andriole KP et al. Recurrent CT, cumulative radiation exposure, and associated radiation-induced cancer risks from CT of adults. Radiology251(1), 175–184 (2009).
   PubMed Web of Science ®Google Scholar
• Brenner DJ, Curtis RE, Hall EJ, Ron E. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer88(2), 398–406 (2000).
   PubMed Web of Science ®Google Scholar
• Boice JD Jr, Engholm G, Kleinerman RA et al. Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat. Res.116(1), 3–55 (1988).
   PubMed Web of Science ®Google Scholar
• Ohgaki H, Kleihues P. Genetic pathways to primary and secondary glioblastoma. Am. J. Pathol.170(5), 1445–1453 (2007).
   PubMed Web of Science ®Google Scholar
• Brat DJ, James CD, Jedlicka AE et al. Molecular genetic alterations in radiation-induced astrocytomas. Am. J. Pathol.154(5), 1431–1438 (1999).
   PubMed Web of Science ®Google Scholar
• Donson AM, Erwin NS, Kleinschmidt-DeMasters BK, Madden JR, Addo-Yobo SO, Foreman NK. Unique molecular characteristics of radiation-induced glioblastoma. J. Neuropath. Exp. Neurol.66(8), 740–749 (2007).
   PubMed Web of Science ®Google Scholar
• Contessa JN, Bhojani MS, Freeze HH, Rehemtulla A, Lawrence TS. Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells. Cancer Res.68(10), 3803–3809 (2008).
   PubMed Web of Science ®Google Scholar
• Wester MD, Wasteson A, Lindstrom A. Targeting malignant glioma cells in vitro using platelet-derived growth factor AA-based conjugates. J. Drug Target.17(4), 268–277 (2009).
   PubMed Web of Science ®Google Scholar
• Ferletta M, Uhrbom L, Olofsson T, Ponten F, Westermark B. Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-β-induced gliomagenesis. Mol. Cancer Res.5(9), 891–897 (2007).
   PubMed Web of Science ®Google Scholar
• Emami B, Lyman J, Brown A et al. Tolerance of normal tissue to therapeutic irradiation. Int. J. Radiat. Oncol. Biol. Phys.21(1), 109–122 (1991).
   PubMed Web of Science ®Google Scholar
• Mayer R, Sminia P. Reirradiation tolerance of the human brain. Int. J. Radiat. Oncol. Biol. Phys.70(5), 1350–1360 (2008).
   PubMed Web of Science ®Google Scholar
• Kreisl TN, Kim L, Moore K et al. Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. J. Clin. Oncol.27(5), 740–745 (2009).
   PubMed Web of Science ®Google Scholar
• Schwer AL, Kavanagh BD, McCammon R et al. Radiographic and histopathologic observations after combined EGFR inhibition and hypofractionated stereotactic radiosurgery in patients with recurrent malignant gliomas. Int. J. Radiat. Oncol. Biol. Phys.73(5), 1352–1357 (2009).
   PubMed Web of Science ®Google Scholar
• Schwer AL, Damek DM, Kavanagh BD et al. A Phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomas. Int. J. Radiat. Oncol. Biol. Phys.70(4), 993–1001 (2008).
   PubMed Web of Science ®Google Scholar
• Kohshi K, Yamamoto H, Nakahara A, Katoh T, Takagi M. Fractionated stereotactic radiotherapy using γ unit after hyperbaric oxygenation on recurrent high-grade gliomas. J. Neurooncol.82(3), 297–303 (2007).
   PubMed Web of Science ®Google Scholar
• Askins MA, Moore BD 3rd. Preventing neurocognitive late effects in childhood cancer survivors. J. Child Neurol.23(10), 1160–1171 (2008).
   PubMed Web of Science ®Google Scholar
• Karachaliou F, Simatos G, Batika P, Michalacos S, Kaldrymides P. Endocrine consequences of childhood malignancies. J. BUON14(1), 27–32 (2009).
   PubMed Web of Science ®Google Scholar
• Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int. J. Radiat. Biol. Phys.65(1), 1–7 (2006).
   PubMed Web of Science ®Google Scholar
• Stern RL. Peripheral dose from a linear accelerator equipped with multileaf collimation. Med. Phys.26(4), 559–563 (1999).
   PubMed Web of Science ®Google Scholar
• Robinson D, Scrimger JW, Field GC, Fallone BG. Shielding considerations for tomotherapy. Med. Phys.27(10), 2380–2384 (2000).
   PubMed Web of Science ®Google Scholar
• Chibani O, Ma CM. Photonuclear dose calculations for high-energy photon beams from Siemens and Varian linacs. Med. Phys.30(8), 1990–2000 (2003).
   PubMed Web of Science ®Google Scholar
• Fogliata A, Yartsev S, Nicolini G et al. On the performances of intensity modulated protons, RapidArc and helical tomotherapy for selected paediatric cases. Radiat. Oncol.4, 2 (2009).
   PubMed Web of Science ®Google Scholar
• Howe GR, Burch JD, Chiarelli AM, Risch HA, Choi BC. An exploratory case–control study of brain tumors in children. Cancer Res.49, 4349–4352 (1989).
   PubMed Web of Science ®Google Scholar
• McCredie M, Maisonneuve P, Boyle P. Perinatal and early postnatal risk factors for malignant brain tumors in New South Wales children. Int. J. Cancer56, 11–15 (1994).
   PubMed Web of Science ®Google Scholar
• Shu XO, Jin F, Linet MS et al. Diagnostic x-ray and ultrasound exposure and risk in childhood cancer. Br. J. Cancer70(3), 531–536 (1994).
   PubMed Web of Science ®Google Scholar
• Schuz J, Kaletsch U, Kaatsch P, Meinert R, Michaelis J. Risk factors for pediatric tumors of the central nervous system: results from a German population-based case–control study. Med. Pediatr. Oncol.36, 274–282 (2001).
   PubMedGoogle Scholar
• Kuijten RR, Bunin GR, Nass CC, Meadows AT. Gestational and familial risk factors for childhood astrocytoma: results of a case–control study. Cancer Res.50, 2608–2612 (1990).
   PubMed Web of Science ®Google Scholar
• Bunin GR, Buckley JD, Boesel CP, Rorke LB, Meadows AT. Risk factors for astrocytic glioma and primitive neuroectodermal tumor of the brain in young children: a report from the Children’s Cancer group. Cancer Epidemiol. Biomarkers Prev.3, 197–204 (1994).
   PubMed Web of Science ®Google Scholar